Curative Biotechnology, Inc.
CUBT • Biotechnology
Strong market move
CUBT-16.67%
vs. previous close $0.90
$0.75
▼ -0.15 (-16.67%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$5.53M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.01Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 15, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:18 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.75
Change-16.67%
Shares Out7.37M
Market Cap$5.53M
Enterprise Value$6.87M
52W Range0.03 - 1.99
Beta1.35
P/E-2.59
P/B-0.88
P/FCF-6.30
EV/EBITDA-4.77
EV/FCF-7.83
Price$0.75
Change-16.67%
Shares Out7.37M
Market Cap$5.53M
Enterprise Value$6.87M
52W Range0.03 - 1.99
Beta1.35
P/E-2.59
P/B-0.88
P/FCF-6.30
EV/EBITDA-4.77
EV/FCF-7.83
Earnings Yield-38.62%
FCF Yield-15.86%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.22
Current Ratio0.01
Quick Ratio0.01
Revenue 5Y-100.00%
Volume100.00
Avg Volume1.49K
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Weak liquidity · 0.01Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.